CN118742291A - 包含非甾体抗炎剂的小管内插入物 - Google Patents
包含非甾体抗炎剂的小管内插入物 Download PDFInfo
- Publication number
- CN118742291A CN118742291A CN202380022602.4A CN202380022602A CN118742291A CN 118742291 A CN118742291 A CN 118742291A CN 202380022602 A CN202380022602 A CN 202380022602A CN 118742291 A CN118742291 A CN 118742291A
- Authority
- CN
- China
- Prior art keywords
- insert
- sustained release
- nepafenac
- release biodegradable
- biodegradable ocular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts or implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263297776P | 2022-01-09 | 2022-01-09 | |
| US63/297,776 | 2022-01-09 | ||
| PCT/US2023/010319 WO2023133276A1 (en) | 2022-01-09 | 2023-01-06 | Intracanalicular insert comprising a non-steroidal anti-inflammatory agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118742291A true CN118742291A (zh) | 2024-10-01 |
Family
ID=87074140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202380022602.4A Pending CN118742291A (zh) | 2022-01-09 | 2023-01-06 | 包含非甾体抗炎剂的小管内插入物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250064760A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4460285A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025503625A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118742291A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3246431A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023133276A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104490861A (zh) * | 2014-11-21 | 2015-04-08 | 三明欣茂药业有限公司 | 一种缓释型奈帕芬胺眼用制剂 |
| US10603274B2 (en) * | 2016-09-30 | 2020-03-31 | Mati Therapeutics Inc. | Ophthalmic drug sustained release formulation and uses thereof |
| AU2020262932B2 (en) * | 2019-04-25 | 2025-11-13 | Ocular Therapeutix, Inc. | Intracanalicular hydrogel inserts for the delivery of anesthetics |
| PT3861985T (pt) * | 2020-02-06 | 2023-08-03 | Ocular Therapeutix Inc | Composições e métodos para tratar doenças oculares |
| PT3884929T (pt) * | 2020-03-25 | 2023-08-09 | Ocular Therapeutix Inc | Implante ocular contendo um inibidor da tirosina cinase |
| EP4216929A1 (en) * | 2020-09-24 | 2023-08-02 | Ocular Therapeutix, Inc. | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent |
-
2023
- 2023-01-06 US US18/726,302 patent/US20250064760A1/en active Pending
- 2023-01-06 JP JP2024541021A patent/JP2025503625A/ja active Pending
- 2023-01-06 WO PCT/US2023/010319 patent/WO2023133276A1/en not_active Ceased
- 2023-01-06 EP EP23737631.4A patent/EP4460285A4/en active Pending
- 2023-01-06 CN CN202380022602.4A patent/CN118742291A/zh active Pending
- 2023-01-06 CA CA3246431A patent/CA3246431A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4460285A4 (en) | 2025-12-31 |
| WO2023133276A1 (en) | 2023-07-13 |
| US20250064760A1 (en) | 2025-02-27 |
| CA3246431A1 (en) | 2023-07-13 |
| EP4460285A1 (en) | 2024-11-13 |
| JP2025503625A (ja) | 2025-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20240051303A (ko) | 전안방내 약물 전달 데포 | |
| US12161753B2 (en) | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent | |
| KR102893953B1 (ko) | 하이드로겔 및 사이클로스포린을 포함하는 지속 방출 생분해성 소관내 삽입체 | |
| KR20240119275A (ko) | 압출된 안구 삽입물 또는 이식물 및 이들의 방법 | |
| JP2025513338A (ja) | in situで形成された共有結合を有する単一溶液ハイドロゲル、該ハイドロゲルを使用する組成物設計及び医療処置 | |
| US12453724B2 (en) | Ocular implant containing a tyrosine kinase inhibitor | |
| US20250064760A1 (en) | Intracanalicular insert comprising a non-steroidal anti-inflammatory agent | |
| US20250114373A1 (en) | Intracanalicular insert comprising an antimicrobial agent | |
| JP2025526731A (ja) | 持続的薬物送達のためのオルガノゲル、その調製及び使用の方法 | |
| EP4142664A1 (en) | Methods of treating allergic conjunctivitis | |
| CN116133664A (zh) | 含有糖皮质激素的眼部插入物 | |
| CN118591369A (zh) | 挤出式眼部插入物或植入物及其方法 | |
| US20220183969A1 (en) | Ocular insert containing a glucocorticoid | |
| HK40090731A (zh) | 包含水凝胶和环孢菌素的持续释放可生物降解泪小管内插入物 | |
| HK40085774A (en) | Methods of treating allergic conjunctivitis | |
| HK40072516B (en) | Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |